A clinical and practice-development guide for aesthetic practitioners
| 🎓 The Consultation Catalyst Masterclass — now booking: View the Masterclass | Free Upcoming Webinar | Book an Enquiry Call |
Introduction
The consultation is the most consequential part of any aesthetic treatment — and the part most consistently undertrained. In an industry that spends enormous resource on injection technique, anatomy, and product knowledge, the structured clinical conversation that precedes every treatment rarely receives the same rigour. The result is predictable: injectors who are technically proficient but find themselves in difficult conversations, managing disappointed patients, or treating people whose presentations they did not adequately assess.
The evidence is clear that aesthetic treatment produces meaningful psychosocial benefit when the right patients are treated for the right reasons. Cohen et al. (2022), in the multicentre HARMONY study, demonstrated that multimodal facial aesthetic treatment significantly improved patients’ self-reported psychological wellbeing, social confidence, and aging appearance appraisal. But those outcomes depend on patient selection and expectation alignment — both of which are functions of the consultation, not the injection.
This blog provides a clinical consultation blueprint: the questions every injector should ask, the red flags they must recognise, and the framework that protects patient safety, informed consent, and long-term clinical relationships. For practitioners who want to develop this as a structured, sustainable skillset, the Consultation Catalyst Masterclass — developed by Acquisition Aesthetics in collaboration with Dr Kamran Amjed MD and built on achieving a 92% consultation-to-treatment conversion rate within a CQC-registered clinic — provides the most comprehensive evidence-based consultation training available in UK aesthetics.
Why the Consultation Matters More Than Injectors Think
Aesthetic procedures are not interventions patients undergo passively. Patients present with a specific psychological relationship to their appearance: a perception gap between how they feel and how they look, a concern they have noticed, a social or professional context driving their decision. The quality of the consultation determines whether treatment addresses that underlying concern meaningfully — or misses it entirely.
The HARMONY data (Cohen et al., 2022) showed improvements in how patients felt “positive, confident, and happy” with their appearance and “comfortable, confident, and positive” in their interactions with others after treatment. These are not merely cosmetic outcomes. They are the goals patients actually bring to consultations, even when they describe them in surface-level terms like “I just want to look a bit fresher.” The injector who understands this — who hears the underlying goal and plans treatment accordingly — produces different results, and different patient relationships, than the one who simply addresses the presenting feature.
There is also a safety dimension. Sarwer and Crerand (2012) reviewed the literature on body dysmorphic disorder (BDD) in aesthetic settings and found that 5–15% of individuals who seek aesthetic medical treatments may suffer from BDD. Original work by Sarwer et al. (1998) found that 7% of a cosmetic surgery sample met diagnostic criteria for BDD. Treating patients with active BDD rarely produces satisfaction and can worsen symptoms. Identifying these presentations is a consultation responsibility, not an optional extra.
The Five Domains of an Effective Aesthetic Consultation
A complete aesthetic consultation covers five clinically distinct domains. Injectors who rush or omit any one of them create risk — to safety, to outcomes, or to the professional relationship.
1. Motivation and Goals: Why Are They Here?
The single most important question in any aesthetic consultation is not “what would you like done?” but rather: “what brought you here today, and what would a successful outcome look like for you?” These questions surface the underlying goal rather than the surface-level request. They reveal whether the patient’s motivation is intrinsic (driven by their own perception) or extrinsic (driven by a partner, a social event, social media, or external pressure), and whether their expectations are realistic.
| Ask | This reveals |
| “What is it about your appearance that concerns you most?” | The specific target of their dissatisfaction, which may differ from what they present as their initial request |
| “How long have you been thinking about this?” | Whether this is a recent impulsive decision or a considered long-term concern |
| “What outcome would make you happy with this treatment?” | Whether expectations are realistic and achievable with the treatment they are requesting |
| “Has anything changed recently that has made this feel more important?” | Whether there is a situational trigger (event, relationship change, social media exposure) that may affect expectation stability |
| “How do you feel about your appearance generally?” | Screens for broader body image dissatisfaction that may indicate BDD or other psychological presentations |
2. Psychological Safety Screening: The Questions Injectors Avoid
The consultation is the only opportunity to identify presentations where aesthetic treatment is unlikely to produce the outcome the patient wants — or where proceeding risks active harm. BDD is the most important of these. Sarwer and Crerand (2012) are explicit: cosmetic treatments rarely produce improvement in BDD symptoms and are not recommended. Identifying the condition before treating — and referring appropriately — is both ethically and legally important.
| 🚨 Consultation Red Flags — Proceed with Caution or Decline Preoccupation with a perceived flaw that is minimal or not visible to othersSignificant distress disproportionate to the feature discussedHistory of multiple treatments for the same concern without achieving satisfactionRequests to exactly replicate a specific person’s appearance (particularly from social media)External pressure driving the decision — partner, colleague, or social comparisonFirst consultation immediately before a major life event (wedding, reunion, job interview)History of threatening or litigious behaviour toward previous practitionersDifficulty describing goals in their own words; over-reliance on edited photos or AI-filtered images |
These are not reasons to automatically refuse treatment, but they are reasons to slow down, probe further, and potentially decline. Documenting this assessment — and the clinical reasoning behind any decision to proceed or decline — is both good practice and medicolegal protection.
| The Consultation Catalyst Masterclass covers psychological screening frameworks, the recognition of BDD presentations, and how to have the declining conversation with compassion and professional clarity. Find out more → |
3. Medical History: The Questions Injectors Skip
A systematic medical history is not bureaucracy. It directly affects treatment decisions, product selection, technique, and aftercare. The following are the areas most commonly under-assessed in aesthetic consultations:
| Area | Why it matters in aesthetic practice |
| Current medications | Anticoagulants increase bruising and affect post-treatment appearance. NSAIDs, antihistamines, and antioxidants antagonise hyaluronidase (relevant for filler reversal planning). Some medications affect wound healing and tissue integrity. |
| Previous aesthetic treatments | Prior filler (volume, product, location, age of product) changes facial anatomy and affects injection planning. Permanent fillers cannot be dissolved and complicate future treatment. Large accumulated filler volumes affect surgical outcomes if surgery is later required. |
| Autoimmune and inflammatory conditions | Active inflammatory conditions, recent flares, or immunosuppressant therapy may be relative contraindications. Certain conditions (lupus, Sjögren’s) affect filler behaviour and healing. |
| Mental health history | Relevant to BDD screening and to understanding how the patient relates to their appearance. Not a contraindication in itself — but important clinical context. |
| Allergy history | Relevant to product selection and hyaluronidase use. Bee/wasp venom allergy is a relative contraindication to Hyalase. Lidocaine allergy affects product selection for fillers containing lidocaine. |
| Herpes simplex virus history | Prior cold sores require antiviral prophylaxis before perioral filler and certain energy-based treatments. |
| Pregnancy and breastfeeding | Contraindication to most aesthetic treatments. Patients do not always volunteer this unprompted. |
| Smoking | Impairs wound healing, increases bruising tendency, and prolongs any recovery period. Relevant to managing expectations. |
4. Informed Consent: It’s a Conversation, Not a Form
Informed consent in aesthetic medicine is frequently reduced to a signature on a pre-printed form. This is both clinically inadequate and legally insufficient. Genuine informed consent requires that the patient understands the proposed treatment, its limitations, the realistic range of outcomes, the material risks, and the alternatives — and has had the opportunity to ask questions. This cannot happen in a three-minute form-signing exercise.
| 📋 Consent Conversation: The Questions to Cover “Do you understand what this treatment does and what it cannot do?” — check comprehension, not just signature”Are there any outcomes you would find unacceptable?” — surfaces concerns that are not always volunteered”Do you understand that results are not guaranteed and that some asymmetry is normal?””Are you aware that fillers, once placed, may not dissolve completely with hyaluronidase on the first attempt?””Do you have any questions about what I’ve described?” — and pause long enough for the answer”Is there anything that has changed in your health or life circumstances since you booked?” — creates a natural opening for late-disclosed contraindications |
The 2018 UK Supreme Court decision in Montgomery v Lanarkshire reinforced that consent must be specific to the material risks of importance to this patient — not merely the statistically significant risks in general. In aesthetic practice, this means discussing the specific concerns of this patient’s anatomy, their particular risk profile, and their stated goals explicitly.
5. Treatment Planning and Expectation Alignment
A treatment plan is not simply a list of areas to inject. It is a clinical communication that connects the patient’s goal to the anatomical findings and proposes a realistic, staged approach that the patient can understand and agree to. The consultation is where this alignment is established — and where the injector’s ability to explain, educate, and manage expectations determines whether the outcome is experienced as a success or a disappointment regardless of the technical result.
| 💡 Treatment Planning Questions to Ask Yourself Before Proposing a Plan Does the patient’s stated goal match what this treatment can deliver?Is the presenting concern primarily a volume issue, a laxity issue, or both? (And have I communicated the distinction?)Have I explained what I am NOT recommending today, and why?Have I discussed staging — and made clear that the first treatment is a starting point, not a final result?Have I set a realistic expectation for how the face will look immediately after treatment versus at 2 weeks?Is the patient rushing to treat before an event, and have I discussed whether the timing is appropriate? |
The Consultation as a Trainable Clinical Skill
The questions and frameworks above are not instinctive. They require deliberate training — practice in asking open questions, reading non-verbal cues, holding difficult conversations, and communicating clinical recommendations with both authority and empathy. These are learnable skills that directly affect patient safety, clinical outcomes, and practice sustainability.
The reality of most aesthetic training is that consultation skills receive a fraction of the time dedicated to injection technique. A practitioner may complete 80 hours of clinical training without ever practising a consultation from opening questions through to informed consent documentation. The result is injectors who are confident with a syringe and uncomfortable in the consultation room — the opposite of what safe, sustainable practice requires.
| Consultation Catalyst Masterclass The structured, ethical consultation framework that builds patient trust, protects clinical practice, and achieves a 92% consultation-to-treatment conversion rate. CPD-certified, face-to-face, developed with Dr Kamran Amjed MD. For doctors, nurses, and medical practitioners who want to grow in aesthetics without pressure or compromise. ➤ View the Masterclass and Book Your Place |
The Consultation and Long-Term Patient Retention
Patient retention — the percentage of patients who return for follow-up and ongoing treatment — is the single most important metric for sustainable aesthetic practice. It is driven almost entirely by the consultation experience, not the technical outcome. A patient who leaves the consultation feeling heard, well-informed, and confident in the practitioner’s clinical judgement will return. A patient who felt rushed, pressured, or inadequately informed will not.
The consultation is therefore not only a safety mechanism and an ethical requirement — it is the foundation of the commercial viability of the practice. Injectors who invest in developing consultation skills are investing directly in their career, not just their clinical training. The Consultation Catalyst Masterclass was built on exactly this premise: that a structured, ethical consultation framework is the most reliable driver of sustainable clinic growth.
Summary for Injectors
- The consultation is where treatment safety, patient alignment, and long-term retention are determined. Technical skill alone is insufficient without structured consultation competence (Cohen et al., 2022).
- 5–15% of patients seeking aesthetic treatments may suffer from BDD; treating these patients rarely resolves their concerns. Structured psychological screening is a consultation responsibility (Sarwer & Crerand, 2012; Sarwer et al., 1998).
- Motivation, medical history, psychological screening, informed consent, and treatment planning are five distinct consultation domains — each requiring specific questions and specific documentation.
- Informed consent is a conversation, not a form. Montgomery v Lanarkshire established that material risks relevant to the specific patient must be discussed explicitly.
- Patient retention is primarily determined by consultation quality, not injection technique. Developing structured consultation skills is an investment in sustainable practice. The Consultation Catalyst Masterclass provides exactly this framework.
| Ready to Transform Your Consultation Practice? The Consultation Catalyst Masterclass is a face-to-face, CPD-certified programme teaching a structured, ethical consultation framework built on clinical expertise and real-world practice. Developed by Acquisition Aesthetics and Dr Kamran Amjed MD. Not a sales course — a lifelong clinical skillset. ➤ Book Your Place on the Consultation Catalyst Masterclass |
Ready to Master the Aesthetic Consultation?
| 📹 Book a Video Call Speak with Angharad or Violetta about the Consultation Catalyst Masterclass and all other training. Book a Call |
| 📋 Course Enquiry Questions about the Masterclass content, CPD certification, or delivery format. Enquire Now |
| 💬 WhatsApp Message us directly — we’ll respond as soon as we can. WhatsApp Us |
🎓 Join our next free webinar — expert-led sessions covering clinical practice, patient assessment, and aesthetic career development.
References
Cohen JL, Rivkin A, Dayan S, et al.. Multimodal facial aesthetic treatment on the appearance of aging, social confidence, and psychological well-being: HARMONY study.. Aesthet Surg J. 2022;42(2):NP115–NP124.. PubMed
Sarwer DB, Wadden TA, Pertschuk MJ, Whitaker LA.. Body image dissatisfaction and body dysmorphic disorder in 100 cosmetic surgery patients.. Plast Reconstr Surg. 1998;101(6):1644–1649.. PubMed
Sarwer DB, Crerand CE.. Body image dysmorphic disorder in persons who undergo aesthetic medical treatments.. Aesthet Surg J. 2012;32(8):999–1009.. PubMed